Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€6.63
05.09.22
-
05.09.23
15.97%
06.09.23

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.18
04.09.22
-
04.09.23
-9.84%
01.10.22

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.30
26.08.22
-
26.08.23
-4.98%
03.09.22

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€4.29
26.08.22
€6.00
26.08.23
-41.69%
13.10.22

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.85
24.08.22
-
24.08.23
-10.03%
03.09.22

Could be worthwhile Investment >10% per year
buy
Alpha Pro Tech Ltd.

Start price
Target price
Perf. (%)
€4.34
23.08.22
€5.00
23.08.23
8.66%
24.08.23

buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€5.40
23.08.22
-
23.08.23
29.96%
09.09.22

Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
08.08.22
-
08.08.26
-
11.03.24

Could be worthwhile Investment >10% per year
buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€4.77
07.08.22
-
07.08.23
4.82%
26.08.22

buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.39
03.08.22
€2.80
03.08.23
-14.19%
20.09.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.91
03.08.22
€3.30
03.08.23
-12.37%
13.10.22

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Helius Medical Technologies Inc

Start price
Target price
Perf. (%)
€1.85
03.08.22
-
03.08.23
-92.76%
14.05.23

buy
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€4.11
28.07.22
-
28.07.23
35.16%
14.05.23

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.16
24.07.22
-
24.07.23
-2.64%
04.09.22

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.54
24.07.22
-
24.07.23
-3.78%
15.10.22

buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.37
21.07.22
€5.30
21.07.23
-21.42%
11.03.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Bausch Health Companies Inc.

Start price
Target price
Perf. (%)
€8.45
11.07.22
-
11.07.23
-39.77%
04.08.22

Capable Management
Probably not worthwhile Investment
Revenue decline/stagnation expected
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.59
11.07.22
-
11.07.23
-80.26%
12.07.23

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.09
10.07.22
-
10.07.23
1.76%
23.07.22

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.59
10.07.22
-
10.07.23
-1.91%
23.07.22

Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€8.93
09.07.22
€4.00
09.07.23
-40.65%
23.07.22

buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.74
04.07.22
-
04.07.23
-5.55%
09.07.22

buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.81
04.07.22
-
04.07.23
-24.63%
06.08.22

Could be worthwhile Investment >10% per year
buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€1.59
30.06.22
-
30.06.23
-46.37%
30.05.23

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.27
27.06.22
-
27.06.23
-4.35%
09.07.22